Trial Search Results
Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients
Three month treatment of acute VTE with Fragmin in pediatric cancer patients
Stanford is currently not accepting patients for this trial.
- Drug: dalteparin
Ages Eligible for Study
N/A - 18 Years
Genders Eligible for Study